Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C. (Q43039274)
Jump to navigation
Jump to search
scientific article published on 21 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C. |
scientific article published on 21 June 2007 |
Statements
1 reference
Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C. (English)
1 reference
Patrick Marcellin
1 reference
Lindsay McNair
1 reference
Yves Horsmans
1 reference
Frederik Nevens
1 reference
Jean-Didier Grange
1 reference
Jean-Pierre Bronowicki
1 reference
Denis Vetter
1 reference
Susan Purdy
1 reference
Varun Garg
1 reference
Leif Bengtsson
1 reference
John Alam
1 reference
21 June 2007
1 reference
1 reference
Identifiers
1 reference